AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

ALLIANCE PHARMA PLC

Report Publication Announcement Mar 18, 2016

7478_rns_2016-03-18_335db621-06ff-4aad-93b6-bdbde80fd245.html

Report Publication Announcement

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5285S

Alliance Pharma PLC

18 March 2016

For immediate release 18 March 2016

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

Notification of Preliminary Results

Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, will announce its preliminary results for the year ended 31 December 2015 on Thursday 7 April 2016.

A briefing for analysts will be held at 10.00am on the morning of the results at the offices of Buchanan, 107 Cheapside, London EC2V 6DN.

For more information please contact Buchanan on 020 7466 5000.

For further information:

### Alliance Pharma plc ### + 44 (0) 1249 466966
John Dawson, Chief Executive
Andrew Franklin, Chief Financial Officer

Sarah Robinson, Company Secretary
www.alliancepharma.co.uk
### Buchanan ### + 44 (0) 20 7466 5000
Mark Court / Sophie Cowles / Jane Glover
Numis Securities Limited + 44 (0) 20 7260 1000
Nominated Adviser: Michael Meade / Freddie Barnfield
Corporate Broking: James Black / Toby Adcock

Notes to editors:

About Alliance

Alliance, founded in 1998, is an international speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has sales in more than 100 countries worldwide via direct sales, joint ventures and a network of distributors.  Alliance has a strong track record of acquiring the rights to established niche products and it currently owns or licenses the rights to approximately 90 pharmaceutical and consumer healthcare products. The Company continues to explore opportunities to expand its product portfolio.

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NORLIFVRVIITLIR

//<![CDATA[$.ajaxSetup({headers: {'__RequestVerificationToken':'y9xF_fJ2D3Jc1jXOIXgBi8RV4KDMRqXIrAisW9bHHWUmwBJ2Bf9dRwXNqKgH8eww4oQ947OiSlfCgZejr8Yq7OY8F90B1_kQx1Mw8q7C-dc1:WyKFhNYU4y3t7kx9VoCnQOAuYucPkPLBsRQOAPS_eMHAX16CUkkb4_Yd41dAHq6TVe3yVYIgbS6nMyuZs2Kxugj07Cc1vsVg-b1TdVQGdFo1'}});//]]>

Talk to a Data Expert

Have a question? We'll get back to you promptly.